Wei, Z., Chen, H., Wang, D., Jiang, Z., Pei, Y., Li, L., Wang, F., Jin, J., Liu, Z., Chen, F., Liu, J., Peng, X. (2025). Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial. Nature Communications. https://doi.org/10.1038/s41467-025-63978-y